Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Ductal Adenocarcinoma × paricalcitol × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Ductal Adenocarcinoma 1

Interventions

paricalcitol 1 mitazalimab 1 Tissue Banks 1 Parturition 1 Oxaliplatin 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Losartan 1 Leucovorin 1 Irinotecan 1 Hydroxychloroquine 1 Glucose 1 Genetic Testing 1 Gemcitabine 1 Fluorouracil 1 Fecal Microbiota Transplantation 1 Capecitabine 1 Biopsy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05365893 2025-04-16

PHL Treatment in Pancreatic Cancer

Fox Chase Cancer Center

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡